Clicky

Achieve Life Sciences, Inc. (ACHV) News

Date Title
Nov 11 ACHV: Commercialization in Focus
Oct 16 Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline
Oct 10 Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting
Oct 1 Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs
Jul 31 Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence
Jul 29 Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank
Jul 25 Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024
May 13 ACHV: First Quarter Results
May 10 Achieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial Results
May 10 Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call Transcript
May 9 Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update
May 6 Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
Apr 29 Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
Apr 25 Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
Apr 11 Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
Apr 1 Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2023 Earnings Call Transcript
Apr 1 ACHV: 2023 Results
Mar 29 Q4 2023 Achieve Life Sciences Inc Earnings Call
Mar 28 Achieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA Approval
Mar 28 Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update